ממשק מוח-מחשב לביש חד-ערוצי ולא פולשני לתעשייה ולשירותי בריאות

Executive Industry Relevance

Wearable, single-channel brain-computer interfaces (BCIs) leveraging steady-state visually evoked potentials (SSVEPs) offer a scalable path to non-invasive human-machine interaction in both industrial and healthcare R&D. This approach enables rapid, quantitative assessment of user intent and cognitive state, supporting translational applications from robotic control to neurorehabilitation. The integration of consumer-grade EEG and XR glasses positions this technology for portfolio expansion into accessible, real-world environments.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables quantitative interrogation of neurophysiological responses to visual stimuli for functional target validation.
• Supports mechanistic de-risking by isolating SSVEP-driven brain activity in response to controlled inputs.
• Facilitates predictive confidence in user-state detection for downstream translational research.

Screening & Assay Development

• Provides a standardized, reproducible platform for evaluating brain signal responses to defined visual paradigms.
• Delivers quantitative EEG outputs (e.g., power spectral density at target frequencies) for robust assay development.
• Enables scalable screening of user engagement and cognitive state in both healthy and clinical populations.

Translational & Preclinical Research

• Aligns with disease-relevant endpoints in neurodevelopmental and neuropsychiatric research, such as ADHD and autism.
• Supports continuity from discovery-stage signal validation to preclinical model testing of neurorehabilitation interventions.
• Provides risk-adjusted data for advancing wearable neurotechnology in translational pipelines.

Pipeline & Workflow Integration

This wearable BCI system bridges early discovery, assay development, and translational research by enabling direct, quantitative measurement of brain responses to controlled visual stimuli.

• Discovery Biology: Supports hypothesis testing of neurocognitive engagement via SSVEP signal extraction and classification.
• Screening: Offers reproducible, quantitative EEG readouts for comparing user responses across conditions and populations.
• Analytics: Provides feature-domain data (e.g., PSD at 10 Hz and 12 Hz) for statistical analysis and classifier training.
• Translational Research: Facilitates alignment with clinical endpoints in neurorehabilitation and industrial human-machine interface studies.
• Enterprise Reuse: Establishes a portable, low-cost platform adaptable to diverse R&D and operational settings.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence in neurophysiological target engagement and user intent detection.
• Operational Value: Enhances standardization, reproducibility, and scalability of brain signal acquisition in real-world settings.
• Strategic Value: Enables informed go/no-go decisions for neurotechnology investments and reduces late-stage biological risk.
• Portfolio Impact: Supports risk-adjusted prioritization of wearable neurotechnology assets for both industrial and healthcare applications.

Implementation Considerations

• Requires expertise in EEG signal processing and classifier development for robust deployment.
• Depends on reliable instrumentation, including dry-electrode EEG and XR glasses, with attention to electrode stability.
• Necessitates cross-team standardization of stimulation protocols and data analysis pipelines.
• Adaptable across user populations but may require optimization for specific neurocognitive paradigms.
• Mechanical stability of electrodes and robustness to noise are practical limitations for broader adoption.

Biopharma FAQs